Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 15, 2020

SELL
$38.5 - $76.05 $192,500 - $380,250
-5,000 Closed
0 $0
Q2 2019

Jul 19, 2019

BUY
$35.45 - $48.2 $177,250 - $241,000
5,000 New
5,000 $236,000
Q4 2018

Feb 01, 2019

SELL
$22.73 - $42.34 $113,650 - $211,700
-5,000 Closed
0 $0
Q3 2018

Oct 25, 2018

BUY
$44.35 - $65.71 $221,750 - $328,549
5,000 New
5,000 $222,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.97B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Buckley Wealth Management, LLC Portfolio

Follow Buckley Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckley Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckley Wealth Management, LLC with notifications on news.